Uswm CT, LLC
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Apr 2037
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 15, 2027The maintenance fee for T Cell Receptors (US 11,725,040) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 6 of 6
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,572,400 | T Cell Receptors In force · High confidence | In force | High confidence | |
| US 11,725,040 | T Cell Receptors In force · High confidence | In force | High confidence | |
| US 12,180,260 | T Cell Receptors In force · Medium confidence | In force | Medium confidence | |
| US 11,286,289 | T Cell Receptors In force · Medium confidence | In force | Medium confidence | |
| US 12,589,151 | T Cell Modification In force · Medium confidence | In force | Medium confidence | |
| US 12,746,272 | Method of Treatment of Cancer or Tumour In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.